Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients

Yiming Wu(Icahn School of Medicine at Mount Sinai), Yuval Itan(Rockefeller University), Judy H. Cho(Cedars-Sinai Medical Center), Talin Haritunians(Cedars-Sinai Medical Center), Steven R. Brant(Rutgers, The State University of New Jersey), Richard H. Duerr(University of Pittsburgh), Anthony W. Segal(Soroka Medical Center), Kyle Gettler(Icahn School of Medicine at Mount Sinai), Patrick Maffucci(Rockefeller University), Dermot McGovern(Salford Royal NHS Foundation Trust), Lee A. Denson(Cincinnati Children's Hospital Medical Center), D.N. Cooper(University of Wales Institute Cardiff), Harry Ostrer(Albert Einstein College of Medicine), Girish N. Nadkarni(Icahn School of Medicine at Mount Sinai), Meltem Ece Kars(New York Proton Center), L. Philip Schumm(Chicago Department of Public Health), Scott B. Snapper(Massachusetts General Hospital), Peter D. Stenson(Cardiff University), John D. Rioux(Institute for Molecular Medicine Finland), Elena Schiff(University College London), Tielman Van Vleck(Shanghai First People's Hospital), Çiğdem Sevim Bayrak(Icahn School of Medicine at Mount Sinai), Aayushee Jain(Child Health and Development Institute), Mamta Giri(Icahn School of Medicine at Mount Sinai), Ksenija Sabic(Child Health and Development Institute), Adam P. Levine, Peng Zhang(Zhejiang Hospital), Dalin Li(Cedars-Sinai Medical Center), Mark S. Silverberg(Sinai Health System), Mark J. Daly(Broad Institute), Subra Kugathasan(Children's Healthcare of Atlanta)
Nature Communications
April 20, 2023
Cited by 18


Related Papers